A phase II trial of induction and consolidation therapy of acute myeloid leukemia with weekly oral idarubicin alone in poor risk elderly patients.
Bouabdallah R, Lefrère F, Rose C, Chaïbi P, Harousseau JL, Vernant JP, Castaigne S, Bauduer F, Zini JM, Coso D, Varet B, Robert J, Fenaux P.
Bouabdallah R, et al.
Leukemia. 1999 Oct;13(10):1491-6. doi: 10.1038/sj.leu.2401522.
Leukemia. 1999.
PMID: 10516747
Clinical Trial.
We have conducted a phase II outpatient trial testing weekly oral administration of idarubicin (ZAVEDOS-ZVD) alone to determine the rate of objective response and toxicity in poor risk acute myeloid leukemia (AML) patients over 60 years of age. ...
We have conducted a phase II outpatient trial testing weekly oral administration of idarubicin (ZAVEDOS-ZVD) alone to determine the r …